Which antibiotic is often used prophylactically to treat suspected ophthalmia neonatorum due to Chlamydia or Gonorrhea?

Prepare for the KMK Live Session General Pharmacy Test. Use flashcards and multiple-choice questions with hints and explanations for each question. Get ready for your exam with confidence!

Multiple Choice

Which antibiotic is often used prophylactically to treat suspected ophthalmia neonatorum due to Chlamydia or Gonorrhea?

Explanation:
Newborn eye prophylaxis aims to prevent ophthalmia neonatorum caused by organisms that can be transmitted during birth, especially Neisseria gonorrhoeae and Chlamydia trachomatis. A topical antibiotic given right after birth provides immediate, local protection with minimal systemic exposure. Erythromycin ointment is the standard choice because it effectively covers the organisms most likely to cause this condition in newborns and has a favorable safety profile for neonates. Chloramphenicol, while broad-spectrum, carries a risk of serious bone marrow suppression and is not preferred for routine prophylaxis. Amoxicillin isn’t used for eye prophylaxis and doesn’t reliably prevent neonatal conjunctivitis. Doxycycline is avoided in infants due to effects on teeth and bone development.

Newborn eye prophylaxis aims to prevent ophthalmia neonatorum caused by organisms that can be transmitted during birth, especially Neisseria gonorrhoeae and Chlamydia trachomatis. A topical antibiotic given right after birth provides immediate, local protection with minimal systemic exposure. Erythromycin ointment is the standard choice because it effectively covers the organisms most likely to cause this condition in newborns and has a favorable safety profile for neonates.

Chloramphenicol, while broad-spectrum, carries a risk of serious bone marrow suppression and is not preferred for routine prophylaxis. Amoxicillin isn’t used for eye prophylaxis and doesn’t reliably prevent neonatal conjunctivitis. Doxycycline is avoided in infants due to effects on teeth and bone development.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy